Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-05

Clinical Trial Update: Botulinum Toxin in the Treatment of Gingival Smile [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating botulinum toxin for gingival smile treatment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Universidade Ibirapuera | Conditions: Smiling | Phase 2 | Status: COMPLETED